Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer.

Studies have indicated that inflammation, in conjunction with the production of reactive oxygen species, may play a key role in lung cancer development. In this study, 250 lung cancer patients and 214 controls were genotyped for polymorphisms of the inflammation-related genes prostaglandin synthase-2/cyclooxygenase-2 (COX2/PTGS2), interleukin-6 (IL6), interleukin-8 (IL8) and peroxisome proliferator-activated receptor gamma (PPARg). We found that carriers of the C allele of a polymorphism in the 3'-UTR of COX2 had a significantly increased risk of lung cancer, with odds ratios of 4.28 (95% CI, 2.44-7.49) for homozygotes and 2.12 (95% CI, 1.25-3.59) for heterozygotes. Additionally, we found that an IL8 promoter polymorphism had a protective effect for lung cancer in female subjects, whereas an IL6 promoter polymorphism was only associated with risk of squamous cell carcinoma. This is the first study implicating polymorphisms in inflammatory genes in the risk of lung cancer.

[1]  Stephen S Hecht,et al.  Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. , 2002, The Lancet. Oncology.

[2]  S. Permutt,et al.  A COMMON FAMILIAL COMPONENT IN LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 1977, The Lancet.

[3]  S. Fischer,et al.  Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells , 1998, The Journal of Biological Chemistry.

[4]  M. Mori,et al.  Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. , 2002, Oncogene.

[5]  K. Xie,et al.  Interleukin-8 and human cancer biology. , 2001, Cytokine & growth factor reviews.

[6]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[7]  B. Aggarwal,et al.  Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. , 2002, Carcinogenesis.

[8]  L. Nabors,et al.  HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. , 2001, Cancer research.

[9]  F. Rampen.  Malignant melanoma: sex differences in survival after evidence of distant metastasis. , 1980, British Journal of Cancer.

[10]  H. Bartsch,et al.  Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  J. Siegfried,et al.  Sex and gender differences in lung cancer. , 2003, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.

[12]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.

[13]  M. Lathrop,et al.  Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. , 2002, Cardiovascular research.

[14]  D. Radzioch,et al.  Polymorphism in the 3′-untranslated region of TNFα mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFα mRNA , 2001 .

[15]  P. Opolon,et al.  Quantitative analysis of Th1, Th2 and TGF‐β1 cytokine expression in tumor, TIL and PBL of non‐small cell lung cancer patients , 1998, International journal of cancer.

[16]  E. White,et al.  Non-Small Cell Lung Cancer Cells Induce Monocytes to Increase Expression of Angiogenic Activity1 , 2001, The Journal of Immunology.

[17]  T. Mitsudomi,et al.  Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  Y. Yatabe,et al.  Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  Y. Yatabe,et al.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.

[20]  F. Green,et al.  Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation* , 2000, The Journal of Biological Chemistry.

[21]  R. Shore,et al.  Aspirin and lung cancer in women , 2002, British Journal of Cancer.

[22]  Rhian F. Walther,et al.  Selective Binding of Steroid Hormone Receptors to Octamer Transcription Factors Determines Transcriptional Synergism at the Mouse Mammary Tumor Virus Promoter* , 1999, The Journal of Biological Chemistry.

[23]  S. Watanabe,et al.  17beta-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production. , 2001, The Journal of investigative dermatology.

[24]  D. Kwiatkowski,et al.  Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. , 2001, American journal of human genetics.

[25]  F. Fitzpatrick,et al.  Inflammation, carcinogenesis and cancer. , 2001, International immunopharmacology.

[26]  F. Yamasawa,et al.  Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[27]  Randall Harris,et al.  Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. , 2002, Oncology reports.

[28]  H. Tilg,et al.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. , 1994, Blood.

[29]  Eric S. Lander,et al.  The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes , 2000, Nature Genetics.

[30]  K. Seibert,et al.  Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. , 2000, Cancer research.

[31]  S. Lippman,et al.  Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  E S Lander,et al.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. , 2000, Nature genetics.

[33]  S M Hanash,et al.  An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  W. Mitzner,et al.  Identification of genes promoting angiogenesis in mouse lung by transcriptional profiling. , 2003, American journal of respiratory cell and molecular biology.

[35]  B. Beutler,et al.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Shirakawa,et al.  Genetic polymorphisms and lung cancer susceptibility: a review. , 2002, Lung cancer.

[37]  D. Stojanovic,et al.  Cytokines in Patients with Lung Cancer , 2003, Scandinavian journal of immunology.

[38]  W. Kuschner,et al.  Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. , 1996, The European respiratory journal.

[39]  D. Kwiatkowski,et al.  Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families , 2000, Thorax.

[40]  S. Humphries,et al.  Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[41]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[42]  F. Rampen,et al.  Female sex is a risk factor for satellite and in-transit recurrences from cutaneous melanoma. , 1984, European journal of cancer & clinical oncology.

[43]  K. Miyamoto,et al.  Activation of peroxisome proliferator-activated receptor-γ stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells , 2002, Oncogene.

[44]  D. Romberger,et al.  Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. , 1997, American journal of respiratory and critical care medicine.

[45]  M. Wick,et al.  Peroxisome Proliferator-Activated Receptor-γ Is a Target of Nonsteroidal Anti-Inflammatory Drugs Mediating Cyclooxygenase-Independent Inhibition of Lung Cancer Cell Growth , 2002 .

[46]  M. Wick,et al.  Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth. , 2002, Molecular pharmacology.

[47]  W. McCarthy,et al.  Endocrine influences on survival from malignant melanoma , 1978, Cancer.

[48]  J. Hogg,et al.  Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). , 2001, American journal of respiratory and critical care medicine.

[49]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[50]  D. Radzioch,et al.  Polymorphism in the 3'-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA. , 2001, Nucleic acids research.

[51]  Johan Auwerx,et al.  A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity , 1998, Nature Genetics.

[52]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[53]  B. Aggarwal,et al.  Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: correlation with induction of cyclooxygenase-2 , 2002 .

[54]  H. Dienemann,et al.  Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking. , 2002, Carcinogenesis.

[55]  S. Cannistra,et al.  Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases , 2001, Human Genetics.

[56]  Gerd Geisslinger,et al.  Cyclooxygenase‐independent actions of cyclooxygenase inhibitors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  K. Matsuo,et al.  Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[58]  P. Boffetta,et al.  Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden , 2002, European Respiratory Journal.

[59]  K. Seibert,et al.  Cyclooxygenase-2 in human pathological disease. , 2002, Advances in experimental medicine and biology.

[60]  A. Sasco,et al.  A case–control study of lung cancer in Casablanca, Morocco , 2002, Cancer Causes & Control.

[61]  C. Harris,et al.  Molecular epidemiology and the genetics of environmental cancer. , 1991, JAMA.

[62]  L. Ermert,et al.  Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.